ArticleCell death & disease2026
MLK4 orchestrates macrophage-induced triple-negative breast cancer invasion and ECM remodeling via enhanced paracrine signaling and NF-κB-MMP axis activation.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined multi-omics profiling and machine learning analysis reveals that Bregs and RPS2 promote bone metastasis in nasopharyngeal carcinoma.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tumor-associated macrophages (TAMs) are important mediators of triple-negative breast cancer (TNBC) progression, yet the molecular mechanisms driving this process remain incompletely defined. In this study, we identified MLK4, a member of the MAP3K family, as a regulator of TAM-driven oncogenic processes in TNBC. Using a co-culture of TNBC cells with macrophages, we demonstrated that high MLK4 expression in TNBC is essential for macrophage-induced cancer cell proliferation, extracellular matrix (ECM) remodeling, migration, and invasion. Mechanistically, we showed that the cross-talk between TAMs and TNBC cells drives tumor aggressiveness via an MLK4-dependent mechanism by enhancing NF-κB activation and downstream matrix metalloproteinases (MMPs) expression. We also identified the most prominently upregulated factors, including CXCL1 and IL-8, during the co-culture of macrophages and TNBC cells. We further showed that MLK4 expression correlates with increased macrophage infiltration in TNBC patient samples, indicating its potential role in shaping the immunosuppressive tumor microenvironment. Summarizing, our findings uncover a paracrine signaling involving CXCL1 and MLK4-NF-κB-MMPs axis, which mediates the interactions between TAMs and TNBC cells, enhancing proliferation, mesenchymal transition, ECM remodeling and cancer invasion. This work elucidates a new mechanism of macrophage-induced tumor progression and highlights MLK4 as a promising therapeutic target for disrupting cancer cells-macrophage reciprocal communication in TNBC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.